In other countries
The same active substances on other registers, the same brand first.
Authorised centrally in the EU
This national listing belongs to a medicine the European Commission authorised for the whole EU.
- Lunsumio SCBrazil · Produtos Roche Químicos e Farmacêuticos S.A.Same brand
- LunsumioCanada · 1 MG / ML · Solution · Hoffmann-LA Roche LimitedSame brand
- Lunsumio SCCanada · 45 MG / ML · Solution · Hoffmann-LA Roche LimitedSame brand
- Lunsumio SCCanada · 5 MG / 0.5 ML · Solution · Hoffmann-LA Roche LimitedSame brand
- LunsumioEuropean Union · Roche Registration GmbHSame brand
- LunsumioCroatiaSame brand
- LunsumioItaly · Concentrato per soluzione per infusione · Roche Registration GMBHSame brand
- Lunsumio 1 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Roche Registration GmbHSame brand
- Lunsumio 30 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Roche Registration GmbHSame brand
- Lunsumio 45 mg oplossing voor injectieNetherlands · Oplossing voor injectie · Roche Registration GmbHSame brand
- Lunsumio®Serbia · 1mg · koncentrat za rastvor za infuziju · Roche DOO BeogradSame brand
- Lunsumio®Serbia · 30mg · koncentrat za rastvor za infuziju · Roche DOO BeogradSame brand
- Lunsumio Concentrate for Solution for Infusion 1MG/MLSingapore · 1 mg/ml · infusion, solution concentrate · Roche Singapore Pte. LTD.Same brand
- Lunsumio Concentrate for Solution for Infusion 30MG/30MLSingapore · 30 mg/30 ml · infusion, solution concentrate · Roche Singapore Pte. LTD.Same brand
- LunsumioUnited States · 1MG/ML, 30MG/30ML · injectable · Genentech INCSame brand
- Lunsumio VeloUnited States · 5MG/0.5ML · Injection · Genentech, Inc.Same brand
- Lunsumio VeloUnited States · 45MG/ML · Injection · Genentech, Inc.Same brand
Packs
| Pack | Code | Status |
|---|---|---|
| LUNSUMIO 5 MG SOLUCION INYECTABLE, 1 vial de 0,5 ml | 769629 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Mosunetuzumab
- Strength
- 5 mg
- Dosage form
- solución inyectable
- Route
- vía subcutánea
- Register
- Spain (AEMPS)
- Status
- Authorised
- Status in the register
- Autorizado, no comercializado
- Authorised
- 13 Jan 2026
- Registration
- 1221649003
- Marketing authorisation holder
- Roche Registration Gmbh
- Procedure
- EU centralised
- Supply
- Uso Hospitalario
- EU number
- EU/1/22/1649